Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Molecular Pharmacology
|
November 1, 1991
Estrogen receptor stereochemistry: ligand binding orientation and influence on biological activity
K Chae, M K Gibson, K S Korach
Endocrinology
|
May 1, 1992
Estrogens modulate the responsiveness of osteoblast-like cells (ROS 17/2.8) stably transfected with estrogen receptor
S Migliaccio, V L Davis, M K Gibson, et al.
Nucleic Acids Research
|
October 10, 1997
Interaction of p53 with the human Rad51 protein
S Buchhop, M K Gibson, X W Wang, et al.
Endocrinology
|
October 11, 1991
The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue
M K Gibson, L A Nemmers, W C Beckman, et al.
Cancer Research
|
December 15, 1995
Abrogation of p53-induced apoptosis by the hepatitis B virus X gene
X W Wang, M K Gibson, W Vermeulen, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
April 1, 1997
Isolation and amino acid sequence of a new long-chain neurotoxin with two chromatographic isoforms (Aa el and Ae e2) from the venom of the Australian death adder (Acanthophis antarcticus)
M I Tyler, K V Retson-Yip, M K Gibson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 16, 2009
Clinical and dosimetric factors associated with a prolonged feeding tube requirement in patients treated with chemoradiotherapy (CRT) for head and neck cancers
A S Gokhale, B T McLaughlin, J C Flickinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2010
Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy
V A Passero, B F Branstetter, Y Shuai, et al.
Oral Oncology
|
June 1, 2017
IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer
L P Stabile, A M Egloff, M K Gibson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 18, 2012
Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck
A Argiris, A P Kotsakis, T Hoang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Molecular Pharmacology
|
November 1, 1991
Estrogen receptor stereochemistry: ligand binding orientation and influence on biological activity
K Chae, M K Gibson, K S Korach
Endocrinology
|
May 1, 1992
Estrogens modulate the responsiveness of osteoblast-like cells (ROS 17/2.8) stably transfected with estrogen receptor
S Migliaccio, V L Davis, M K Gibson, et al.
Nucleic Acids Research
|
October 10, 1997
Interaction of p53 with the human Rad51 protein
S Buchhop, M K Gibson, X W Wang, et al.
Endocrinology
|
October 11, 1991
The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue
M K Gibson, L A Nemmers, W C Beckman, et al.
Cancer Research
|
December 15, 1995
Abrogation of p53-induced apoptosis by the hepatitis B virus X gene
X W Wang, M K Gibson, W Vermeulen, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
April 1, 1997
Isolation and amino acid sequence of a new long-chain neurotoxin with two chromatographic isoforms (Aa el and Ae e2) from the venom of the Australian death adder (Acanthophis antarcticus)
M I Tyler, K V Retson-Yip, M K Gibson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 16, 2009
Clinical and dosimetric factors associated with a prolonged feeding tube requirement in patients treated with chemoradiotherapy (CRT) for head and neck cancers
A S Gokhale, B T McLaughlin, J C Flickinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2010
Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy
V A Passero, B F Branstetter, Y Shuai, et al.
Oral Oncology
|
June 1, 2017
IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer
L P Stabile, A M Egloff, M K Gibson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 18, 2012
Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck
A Argiris, A P Kotsakis, T Hoang, et al.
Page
of 2